Hair Loss Relief Cosmetic Developed by KAERI Spin-off Firm Receives KFDA Approval

The Korea Atomic Energy Research Institute (KAERI) is set to introduce a functional cosmetic product for hair loss relief, featuring "Maysin," a natural substance extracted from centipede grass, as its main ingredient.

According to KAERI on Thursday (July 2), a hair tonic product based on Maysin—a substance previously used in various fields such as skin soothing, UV protection, and sports care—has officially passed the Ministry of Food and Drug Safety's review for functional cosmetics aimed at alleviating hair loss symptoms.

Maysin is a natural flavonoid component found in trace amounts in corn silk or centipede grass, a type of turfgrass, and is known for its excellent antioxidant and anti-inflammatory effects.

It is considered a high-value natural material because chemical synthesis is difficult.

In 2012, KAERI succeeded in isolating and purifying Maysin from centipede grass, a perennial warm-season turfgrass, for the first time in the world.

To increase the Maysin content, the research team at KAERI's Advanced Radiation Technology Institute used radiation to create a Maysin extract with a concentration 2.7 times higher than that of natural Maysin.

KAERI explained that while mass production is impossible using corn silk due to the extremely small amount of Maysin it contains, centipede grass contains nearly three times as much and can be produced year-round as it is a type of turfgrass.

The product that passed the ministry's review is "Maysera Revive & Restore Hair Tonic," a spray-type functional cosmetic for hair loss relief developed by BioMaysin, KAERI's 8th spin-off company.

Unlike existing products that primarily focus on scalp environment management and appearance improvement, Maysera focuses on managing hair cell growth.

The research team explained that human application tests confirmed an improvement in hair density. After 24 weeks of use, all members of the test group reported positive results regarding hair loss symptoms, crown fullness, and hairline improvement, with no adverse scalp reactions such as itching or stinging reported during the test period.

Lim In-chul, Acting President of KAERI, stated, "This achievement is the result of combining the institute's core technology with the commercialization capabilities of our spin-off company," adding, "We will continue to vitalize the technology commercialization ecosystem so that spin-off companies can grow based on our research outcomes."

(Photo: Provided by KAERI, Yonhap News)

※ Please note: This article was translated by AI and may contain errors.